nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Pregnancy—Captopril—systemic scleroderma	0.0254	0.0254	CcSEcCtD
Gadobutrol—Urine abnormality—Mycophenolic acid—systemic scleroderma	0.0204	0.0204	CcSEcCtD
Gadobutrol—Pregnancy—Mycophenolic acid—systemic scleroderma	0.0199	0.0199	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Mycophenolic acid—systemic scleroderma	0.0193	0.0193	CcSEcCtD
Gadobutrol—Urine abnormality—Mycophenolate mofetil—systemic scleroderma	0.0161	0.0161	CcSEcCtD
Gadobutrol—Apathy—Mycophenolic acid—systemic scleroderma	0.0158	0.0158	CcSEcCtD
Gadobutrol—Micturition urgency—Mycophenolate mofetil—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Gadobutrol—Flat affect—Mycophenolic acid—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Mycophenolate mofetil—systemic scleroderma	0.0152	0.0152	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.0142	0.0142	CcSEcCtD
Gadobutrol—Aphasia—Mycophenolate mofetil—systemic scleroderma	0.0138	0.0138	CcSEcCtD
Gadobutrol—Apathy—Mycophenolate mofetil—systemic scleroderma	0.0125	0.0125	CcSEcCtD
Gadobutrol—Flat affect—Mycophenolate mofetil—systemic scleroderma	0.0124	0.0124	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Captopril—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Gadobutrol—Abnormal vision—Mycophenolic acid—systemic scleroderma	0.00987	0.00987	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Captopril—systemic scleroderma	0.00955	0.00955	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.0089	0.0089	CcSEcCtD
Gadobutrol—Pollakiuria—Captopril—systemic scleroderma	0.00834	0.00834	CcSEcCtD
Gadobutrol—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00813	0.00813	CcSEcCtD
Gadobutrol—Aphasia—Methotrexate—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Gadobutrol—Abnormal vision—Mycophenolate mofetil—systemic scleroderma	0.00779	0.00779	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00765	0.00765	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00751	0.00751	CcSEcCtD
Gadobutrol—Palpitations—Pentoxifylline—systemic scleroderma	0.00734	0.00734	CcSEcCtD
Gadobutrol—Sweating increased—Leflunomide—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Gadobutrol—Convulsion—Pentoxifylline—systemic scleroderma	0.0072	0.0072	CcSEcCtD
Gadobutrol—Dry mouth—Pentoxifylline—systemic scleroderma	0.00691	0.00691	CcSEcCtD
Gadobutrol—Pollakiuria—Leflunomide—systemic scleroderma	0.00688	0.00688	CcSEcCtD
Gadobutrol—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00678	0.00678	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Gadobutrol—Infection—Pentoxifylline—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Gadobutrol—Pollakiuria—Mycophenolic acid—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Gadobutrol—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00655	0.00655	CcSEcCtD
Gadobutrol—Sweating increased—Lisinopril—systemic scleroderma	0.00623	0.00623	CcSEcCtD
Gadobutrol—Dysgeusia—Captopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Gadobutrol—Insomnia—Pentoxifylline—systemic scleroderma	0.00613	0.00613	CcSEcCtD
Gadobutrol—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Gadobutrol—Dry mouth—Mometasone—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Gadobutrol—Anaphylactic shock—Mometasone—systemic scleroderma	0.00585	0.00585	CcSEcCtD
Gadobutrol—Infection—Mometasone—systemic scleroderma	0.00581	0.00581	CcSEcCtD
Gadobutrol—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.00566	0.00566	CcSEcCtD
Gadobutrol—Palpitations—Captopril—systemic scleroderma	0.00556	0.00556	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Gadobutrol—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Gadobutrol—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Gadobutrol—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Gadobutrol—Paraesthesia—Mometasone—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Gadobutrol—Dry mouth—Captopril—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Gadobutrol—Dyspnoea—Mometasone—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Gadobutrol—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Gadobutrol—Anaphylactic shock—Captopril—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Gadobutrol—Dysgeusia—Leflunomide—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Gadobutrol—Pain—Mometasone—systemic scleroderma	0.005	0.005	CcSEcCtD
Gadobutrol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Gadobutrol—Vertigo—Leflunomide—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Gadobutrol—Insomnia—Captopril—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Gadobutrol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Gadobutrol—Abdominal pain—Mometasone—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Gadobutrol—Body temperature increased—Mometasone—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Gadobutrol—Paraesthesia—Captopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Gadobutrol—Palpitations—Leflunomide—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Gadobutrol—Dyspnoea—Captopril—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Gadobutrol—Dizziness—Pentoxifylline—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Gadobutrol—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Gadobutrol—Infection—Azathioprine—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Gadobutrol—Vertigo—Mycophenolic acid—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Gadobutrol—Palpitations—Mycophenolic acid—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Gadobutrol—Dysgeusia—Lisinopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Gadobutrol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Gadobutrol—Dry mouth—Leflunomide—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Gadobutrol—Vomiting—Pentoxifylline—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Gadobutrol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Gadobutrol—Rash—Pentoxifylline—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Gadobutrol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Gadobutrol—Headache—Pentoxifylline—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Gadobutrol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Gadobutrol—Infection—Leflunomide—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Captopril—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Gadobutrol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Gadobutrol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Gadobutrol—Abdominal pain—Captopril—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Gadobutrol—Body temperature increased—Captopril—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Gadobutrol—Nausea—Pentoxifylline—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Gadobutrol—Infection—Mycophenolic acid—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Gadobutrol—Vertigo—Lisinopril—systemic scleroderma	0.004	0.004	CcSEcCtD
Gadobutrol—Diarrhoea—Mometasone—systemic scleroderma	0.004	0.004	CcSEcCtD
Gadobutrol—Palpitations—Lisinopril—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Gadobutrol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Gadobutrol—Insomnia—Leflunomide—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Gadobutrol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Gadobutrol—Paraesthesia—Leflunomide—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Gadobutrol—Dyspnoea—Leflunomide—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Gadobutrol—Vomiting—Mometasone—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Gadobutrol—Dry mouth—Lisinopril—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Gadobutrol—Sweating increased—Prednisone—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Gadobutrol—Rash—Mometasone—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Gadobutrol—Dermatitis—Mometasone—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Gadobutrol—Headache—Mometasone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Gadobutrol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Gadobutrol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Gadobutrol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Gadobutrol—Pain—Leflunomide—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Gadobutrol—Infection—Lisinopril—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Gadobutrol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Gadobutrol—Body temperature increased—Azathioprine—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Gadobutrol—Abdominal pain—Azathioprine—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Gadobutrol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Gadobutrol—Diarrhoea—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Gadobutrol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Gadobutrol—Nausea—Mometasone—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Gadobutrol—Pain—Mycophenolic acid—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Gadobutrol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Gadobutrol—Dizziness—Captopril—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Gadobutrol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Gadobutrol—Body temperature increased—Leflunomide—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Gadobutrol—Abdominal pain—Leflunomide—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Gadobutrol—Hypersensitivity—Azathioprine—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Gadobutrol—Insomnia—Lisinopril—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Gadobutrol—Paraesthesia—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Gadobutrol—Vomiting—Captopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Gadobutrol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Gadobutrol—Dyspnoea—Lisinopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Gadobutrol—Rash—Captopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Gadobutrol—Dermatitis—Captopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Gadobutrol—Headache—Captopril—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Gadobutrol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Gadobutrol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Gadobutrol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Gadobutrol—Infection—Mycophenolate mofetil—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Gadobutrol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Gadobutrol—Pain—Lisinopril—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Gadobutrol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Gadobutrol—Diarrhoea—Azathioprine—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Gadobutrol—Nausea—Captopril—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Gadobutrol—Dizziness—Azathioprine—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Gadobutrol—Diarrhoea—Leflunomide—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Gadobutrol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Gadobutrol—Abdominal pain—Lisinopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Gadobutrol—Body temperature increased—Lisinopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Gadobutrol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Gadobutrol—Vomiting—Azathioprine—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Gadobutrol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Gadobutrol—Rash—Azathioprine—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Gadobutrol—Dermatitis—Azathioprine—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Gadobutrol—Headache—Azathioprine—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Gadobutrol—Dizziness—Leflunomide—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Gadobutrol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Gadobutrol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Gadobutrol—Vomiting—Leflunomide—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Gadobutrol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Gadobutrol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gadobutrol—Rash—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gadobutrol—Dermatitis—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gadobutrol—Nausea—Azathioprine—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Gadobutrol—Headache—Leflunomide—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Gadobutrol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Gadobutrol—Rash—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gadobutrol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Gadobutrol—Headache—Mycophenolic acid—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Gadobutrol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Gadobutrol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Gadobutrol—Nausea—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Gadobutrol—Diarrhoea—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Gadobutrol—Visual impairment—Methotrexate—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Gadobutrol—Dizziness—Lisinopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Gadobutrol—Nausea—Mycophenolic acid—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Gadobutrol—Vertigo—Prednisone—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Gadobutrol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Gadobutrol—Vomiting—Lisinopril—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Gadobutrol—Rash—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Gadobutrol—Convulsion—Prednisone—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Gadobutrol—Dermatitis—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Gadobutrol—Headache—Lisinopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Gadobutrol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Gadobutrol—Dysgeusia—Methotrexate—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Gadobutrol—Nausea—Lisinopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gadobutrol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gadobutrol—Infection—Prednisone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Gadobutrol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Gadobutrol—Hyperhidrosis—Prednisone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Gadobutrol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Gadobutrol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Gadobutrol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Gadobutrol—Headache—Mycophenolate mofetil—systemic scleroderma	0.002	0.002	CcSEcCtD
Gadobutrol—Vertigo—Methotrexate—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Gadobutrol—Insomnia—Prednisone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Gadobutrol—Paraesthesia—Prednisone—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Gadobutrol—Convulsion—Methotrexate—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Gadobutrol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Gadobutrol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Gadobutrol—Infection—Methotrexate—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Gadobutrol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Gadobutrol—Abdominal pain—Prednisone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gadobutrol—Body temperature increased—Prednisone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Gadobutrol—Insomnia—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Gadobutrol—Paraesthesia—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Gadobutrol—Dyspnoea—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Gadobutrol—Hypersensitivity—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Gadobutrol—Pain—Methotrexate—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Gadobutrol—Diarrhoea—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Gadobutrol—Dizziness—Prednisone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gadobutrol—Abdominal pain—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gadobutrol—Body temperature increased—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Gadobutrol—Vomiting—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Gadobutrol—Rash—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Gadobutrol—Dermatitis—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Gadobutrol—Headache—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Gadobutrol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Gadobutrol—Nausea—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Gadobutrol—Diarrhoea—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Gadobutrol—Dizziness—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Gadobutrol—Vomiting—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Gadobutrol—Rash—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gadobutrol—Dermatitis—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gadobutrol—Headache—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Gadobutrol—Nausea—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
